Zobrazeno 1 - 10
of 10
pro vyhledávání: '"excision repair cross complementing protein 1"'
Autor:
Pier G. Mastroberardino, Silvia Cerri, Yvonne Rijksen, Wilfred F. J. van IJcken, Sylvia Gabriels, Kasper W.J. Derks, Sara Sepe, Alex L. Nigg, Sandra Moreno, Fabio Blandini, Jan H.J. Hoeijmakers, César Payán-Gómez, Chiara Milanese
Publikováno v:
Cell Reports, Vol 15, Iss 9, Pp 1866-1875 (2016)
Cell Reports, 15(9), 1866-1875. Cell Press
Cell Reports
Ahmad, A., Robinson, A.R., Duensing, A., van Drunen, E., Beverloo, H.B., Weisberg, D.B., Hasty, P., Niedernhofer, L.J., ERCC1-XPF endonuclease facilitates DNA double-strand break repair (2008) Mol. Cell. Biol., 28, pp. 5082-5092
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Cell Reports, 15(9), 1866-1875. Cell Press
Cell Reports
Ahmad, A., Robinson, A.R., Duensing, A., van Drunen, E., Beverloo, H.B., Weisberg, D.B., Hasty, P., Niedernhofer, L.J., ERCC1-XPF endonuclease facilitates DNA double-strand break repair (2008) Mol. Cell. Biol., 28, pp. 5082-5092
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Summary The underlying relation between Parkinson’s disease (PD) etiopathology and its major risk factor, aging, is largely unknown. In light of the causative link between genome stability and aging, we investigate a possible nexus between DNA dama
Autor:
Chun‑Wei Xu, Jin‑Nv Fang, Li‑Ying Zhang, Gang Wang, Yu‑Ping Zhang, Yu‑Wang Tian, Chuan‑Jun Han, Lin Wang, Jing‑Shan Gao, Yang Li, Wu‑Long Wang, Wen‑Bin Gao
Publikováno v:
Experimental and Therapeutic Medicine
The present study aimed to investigate the association between epidermal growth factor receptor (EGFR) gene mutations and excision repair cross-complementing protein 1 (ERCC1) and ribonucleotide reductase subunit M1 (RRM1) mRNA expression in non-smal
Autor:
Nikitas, N., Karadimou, A., Tsitoura, E., Soupos, N., Tsiatas, M., Karavasilis, V., Pectasides, Dimitrios, Pavlidis, Nicholas, Chrisofos, M., Adamakis, I., Murray, S., Fountzilas, George, Dimopoulos, M. A., Bamias, A. T.
Publikováno v:
Pharmacogenomics
Aim: The association between two polymorphisms of ERCC1 and treatment outcomes after platinum-based chemotherapy in patients with advanced urothelial cancer (UC) was examined. Materials & methods: Genotyping of 19007C>T and 8092C>A polymorphisms was
Autor:
Ozkan Kanat, Ozlem Saraydaroglu, Turkkan Evrensel, Ömer Fatih Ölmez, Erdem Cubukcu, Unsal Akcali, Ender Kurt, Osman Manavoglu
Publikováno v:
Clinical and Translational Oncology. 13:826-830
INTRODUCTION The identification of novel prognostic markers may help to better assess survival probability in different subgroups of patients with non-small-cell lung cancer (NSCLC) and to tailor treatment according to the molecular profile of the tu
Autor:
Levent Elmas, Vildan Caner, G. Ozan Çetin, Gulseren Bagci, Nur Büyükpınarbaşılı, Emre Tepeli, Füsun Düzcan
Publikováno v:
Molecular Biology Reports. 39:335-341
Excision Repair Cross-Complementing Group 1 (ERCC1) is an important DNA repair gene, playing critical role in nucleotide excision repair pathway and having a significant influence on genomic instability. Some studies support that ERCC1 might be a pot
Publikováno v:
Health Economics Review 3 (2013), Nr. 1
Background: Lung cancer is one of the leading causes of cancer deaths. Treatment goals are the relief of symptoms and the increase of overall survival. With the rising number of treatment alternatives, the need for comparable assessments of health-re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7337e5c074caeba0e1006c1e9ae60018
Autor:
Pentheroudakis, George, Batistatou, Anna, Kalogeras, K. T., Kronenwett, R., Wirtz, R. M., Bournakis, E., Eleftheraki, A. G., Pectasides, Dimitrios, Bobos, M., Papaspirou, I., Kamina, S., Gogas, H., Koutras, A. K., Pavlidis, Nicholas, Fountzilas, George
Publikováno v:
Breast cancer research and treatment
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2011, 127 (1), pp.179-193. ⟨10.1007/s10549-011-1427-0⟩
Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, Springer Verlag, 2011, 127 (1), pp.179-193. ⟨10.1007/s10549-011-1427-0⟩
We evaluated the prognostic and predictive utility of β-tubulin isotype III (TUBB3) tumour gene transcription in early breast cancer patients enrolled in a randomised study. Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec7973de11ace1d6dddf303afee14aa8
https://gnosis.library.ucy.ac.cy/handle/7/42338
https://gnosis.library.ucy.ac.cy/handle/7/42338
Autor:
Eloisa Jantus-Lewintre, Carlos Camps, Vega Iranzo, Sara Blasco, Ana Blasco, Roy M. Bremnes, Rafael Sirera, Alfonso Berrocal, Miquel Taron, Nieves del Pozo, Rafael Rosell, Cristina Caballero
Publikováno v:
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
instname
instname
[EN] Background: Platinum doublets are standard chemotherapy for advanced non-small-cell lung cancer (NSCLC). The aim of this study was to assess whether neutropenia is: (1) an indicator for treatment efficacy, or (2) associated with specific polymor
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.